Glendon E. French III - Jun 1, 2021 Form 4 Insider Report for Pulmonx Corp (LUNG)

Role
President and CEO, Director
Signature
/s/ Lauren Cristina, Attorney-in-Fact for Glendon E. French
Stock symbol
LUNG
Transactions as of
Jun 1, 2021
Transactions value $
$0
Form type
4
Date filed
6/11/2021, 08:15 PM
Previous filing
Dec 3, 2021
Next filing
Jun 21, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LUNG Common Stock Award $0 +45.6K +3.79% $0.00 1.25M Jun 1, 2021 Direct F1, F2
holding LUNG Common Stock 26.6K Jun 1, 2021 See footnote F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LUNG Employee Stock Option (right to buy) Award $0 +104K $0.00 104K Jun 1, 2021 Common Stock 104K $43.40 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents grant of Restricted Stock Units payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on June 1, 2021.
F2 Includes 2,500 shares acquired by the Reporting Person under the Issuer's 2020 Employee Stock Purchase Plan on May 24, 2021.
F3 The shares are directly held by the Glendon E. French III Children's Irrevocable Trust dated 11-17-98 for which the Reporting Person is a trustee.
F4 The shares subject to the option vest in 48 equal monthly installments beginning on June 1, 2021.